Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.

Globally, Latin America ranks third among regions with most cases of AIDS related cryptococcal meningitis. In 2009, a lateral flow immunoassay (LFA) for the detection of cryptococcal antigen (CrAg) was developed as a potential point-of-care test for diagnosis of cryptococcal infection. In 2011 World...

Full description

Bibliographic Details
Main Authors: Claudia Frola, Liliana Guelfand, Gabriela Blugerman, Edgardo Szyld, Sara Kaufman, Pedro Cahn, Omar Sued, Héctor Pérez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5472272?pdf=render
_version_ 1818176153264848896
author Claudia Frola
Liliana Guelfand
Gabriela Blugerman
Edgardo Szyld
Sara Kaufman
Pedro Cahn
Omar Sued
Héctor Pérez
author_facet Claudia Frola
Liliana Guelfand
Gabriela Blugerman
Edgardo Szyld
Sara Kaufman
Pedro Cahn
Omar Sued
Héctor Pérez
author_sort Claudia Frola
collection DOAJ
description Globally, Latin America ranks third among regions with most cases of AIDS related cryptococcal meningitis. In 2009, a lateral flow immunoassay (LFA) for the detection of cryptococcal antigen (CrAg) was developed as a potential point-of-care test for diagnosis of cryptococcal infection. In 2011 World Health Organizations recommended on CrAg screening for HIV positive persons with CD4 below 100 cells/μL, followed by preemptive fluconazole treatment. However, in Argentina no formal recommendations for CrAg screening have been issued.HIV positive patients > = 18 years with advanced immunosuppression (CD4 counts ≤100 cells/μL within 3 months or WHO stage III/IV), who visited the hospital between April 1, 2014 and January 31, 2015, were included. The LFA was performed according to the manufacturer's instructions on all serum samples. When CrAg detection was positive, a lumbar puncture was performed to rule out cryptococcal meningitis. Patients without evidence of meningeal involvement were treated with preemptive oral fluconazole in ambulatory care.We included 123 patients. Prevalence of CrAg-positivity was 8.1%. Among the 10 CrAg-positive patients, 6 had meningeal involvement detected through the CSF analysis (CSF India-ink testing, CSF CrAg and culture). The remaining 4 patients with positive CrAg received targeted preemptive treatment with oral fluconazole and were free of cryptococcal disease during the follow-up period. None of the 113 patients with a negative CrAg test result developed cryptococcal disease.This is the first study in Argentina, to our knowledge, describing the prevalence of cryptococcosis and usefulness of CrAg screening. LFA provided early diagnosis to determine a high prevalence of CrAg in our hospital, and that screening for subclinical infection with preemptive antifungal treatment, prevented a substantial proportion of meningeal disease.
first_indexed 2024-12-11T20:11:40Z
format Article
id doaj.art-75d03957b8894ee69d192b08b0474308
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T20:11:40Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-75d03957b8894ee69d192b08b04743082022-12-22T00:52:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017872110.1371/journal.pone.0178721Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.Claudia FrolaLiliana GuelfandGabriela BlugermanEdgardo SzyldSara KaufmanPedro CahnOmar SuedHéctor PérezGlobally, Latin America ranks third among regions with most cases of AIDS related cryptococcal meningitis. In 2009, a lateral flow immunoassay (LFA) for the detection of cryptococcal antigen (CrAg) was developed as a potential point-of-care test for diagnosis of cryptococcal infection. In 2011 World Health Organizations recommended on CrAg screening for HIV positive persons with CD4 below 100 cells/μL, followed by preemptive fluconazole treatment. However, in Argentina no formal recommendations for CrAg screening have been issued.HIV positive patients > = 18 years with advanced immunosuppression (CD4 counts ≤100 cells/μL within 3 months or WHO stage III/IV), who visited the hospital between April 1, 2014 and January 31, 2015, were included. The LFA was performed according to the manufacturer's instructions on all serum samples. When CrAg detection was positive, a lumbar puncture was performed to rule out cryptococcal meningitis. Patients without evidence of meningeal involvement were treated with preemptive oral fluconazole in ambulatory care.We included 123 patients. Prevalence of CrAg-positivity was 8.1%. Among the 10 CrAg-positive patients, 6 had meningeal involvement detected through the CSF analysis (CSF India-ink testing, CSF CrAg and culture). The remaining 4 patients with positive CrAg received targeted preemptive treatment with oral fluconazole and were free of cryptococcal disease during the follow-up period. None of the 113 patients with a negative CrAg test result developed cryptococcal disease.This is the first study in Argentina, to our knowledge, describing the prevalence of cryptococcosis and usefulness of CrAg screening. LFA provided early diagnosis to determine a high prevalence of CrAg in our hospital, and that screening for subclinical infection with preemptive antifungal treatment, prevented a substantial proportion of meningeal disease.http://europepmc.org/articles/PMC5472272?pdf=render
spellingShingle Claudia Frola
Liliana Guelfand
Gabriela Blugerman
Edgardo Szyld
Sara Kaufman
Pedro Cahn
Omar Sued
Héctor Pérez
Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
PLoS ONE
title Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
title_full Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
title_fullStr Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
title_full_unstemmed Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
title_short Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
title_sort prevalence of cryptococcal infection among advanced hiv patients in argentina using lateral flow immunoassay
url http://europepmc.org/articles/PMC5472272?pdf=render
work_keys_str_mv AT claudiafrola prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT lilianaguelfand prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT gabrielablugerman prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT edgardoszyld prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT sarakaufman prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT pedrocahn prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT omarsued prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay
AT hectorperez prevalenceofcryptococcalinfectionamongadvancedhivpatientsinargentinausinglateralflowimmunoassay